vs
MICROVISION, INC.（MVIS）与Varex Imaging Corp（VREX）财务数据对比。点击上方公司名可切换其他公司
Varex Imaging Corp的季度营收约是MICROVISION, INC.的939.9倍（$209.6M vs $223.0K）。Varex Imaging Corp净利率更高（1.1% vs -16930.9%，领先16932.0%）。Varex Imaging Corp同比增速更快（4.9% vs -86.5%）。MICROVISION, INC.自由现金流更多（$-15.6M vs $-26.8M）。过去两年Varex Imaging Corp的营收复合增速更高（0.8% vs -51.7%）
MicroVision Inc.是一家专注于激光雷达传感器、微型显示解决方案与感知软件研发的科技企业，核心产品覆盖车载高级驾驶辅助系统、AR设备、消费电子及工业自动化等领域，为各类下一代智能应用提供高精度、低功耗的技术支持。
Varex Imaging是全球知名的影像组件及解决方案供应商，核心产品涵盖X射线管、数字平板探测器和图像处理软件，广泛应用于医疗诊断、放射肿瘤治疗及工业无损检测等领域，客户覆盖全球主要市场。
MVIS vs VREX — 直观对比
营收规模更大
VREX
是对方的939.9倍
$223.0K
营收增速更快
VREX
高出91.4%
-86.5%
净利率更高
VREX
高出16932.0%
-16930.9%
自由现金流更多
MVIS
多$11.2M
$-26.8M
两年增速更快
VREX
近两年复合增速
-51.7%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $223.0K | $209.6M |
| 净利润 | $-37.8M | $2.3M |
| 毛利率 | -7220.6% | 33.3% |
| 营业利润率 | -18570.0% | 7.3% |
| 净利率 | -16930.9% | 1.1% |
| 营收同比 | -86.5% | 4.9% |
| 净利润同比 | -21.2% | 866.7% |
| 每股收益（稀释后） | $-0.12 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MVISVREX
| Q1 26 | — | $209.6M | ||
| Q4 25 | $223.0K | $228.9M | ||
| Q3 25 | $241.0K | $203.0M | ||
| Q2 25 | $155.0K | $212.9M | ||
| Q1 25 | $589.0K | $199.8M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $190.0K | $205.7M | ||
| Q2 24 | $1.9M | $209.1M |
净利润MVISVREX
| Q1 26 | — | $2.3M | ||
| Q4 25 | $-37.8M | $12.2M | ||
| Q3 25 | $-14.2M | $-89.1M | ||
| Q2 25 | $-14.2M | $6.9M | ||
| Q1 25 | $-28.8M | $-300.0K | ||
| Q4 24 | $-31.2M | — | ||
| Q3 24 | $-15.5M | $-51.1M | ||
| Q2 24 | $-23.9M | $1.4M |
毛利率MVISVREX
| Q1 26 | — | 33.3% | ||
| Q4 25 | -7220.6% | 34.0% | ||
| Q3 25 | -297.1% | 33.3% | ||
| Q2 25 | -361.9% | 36.0% | ||
| Q1 25 | 6.6% | 34.3% | ||
| Q4 24 | -149.5% | — | ||
| Q3 24 | -206.8% | 32.6% | ||
| Q2 24 | 18.2% | 32.0% |
营业利润率MVISVREX
| Q1 26 | — | 7.3% | ||
| Q4 25 | -18570.0% | 8.6% | ||
| Q3 25 | -5278.4% | -39.8% | ||
| Q2 25 | -9455.5% | 10.4% | ||
| Q1 25 | -2383.7% | 5.6% | ||
| Q4 24 | -1119.5% | — | ||
| Q3 24 | -8266.3% | 5.3% | ||
| Q2 24 | -1296.4% | 4.4% |
净利率MVISVREX
| Q1 26 | — | 1.1% | ||
| Q4 25 | -16930.9% | 5.3% | ||
| Q3 25 | -5899.2% | -43.9% | ||
| Q2 25 | -9180.0% | 3.2% | ||
| Q1 25 | -4886.1% | -0.2% | ||
| Q4 24 | -1888.2% | — | ||
| Q3 24 | -8166.8% | -24.8% | ||
| Q2 24 | -1259.5% | 0.7% |
每股收益（稀释后）MVISVREX
| Q1 26 | — | $0.05 | ||
| Q4 25 | $-0.12 | $0.29 | ||
| Q3 25 | $-0.05 | $-2.15 | ||
| Q2 25 | $-0.06 | $0.17 | ||
| Q1 25 | $-0.12 | $-0.01 | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | $-0.07 | $-1.25 | ||
| Q2 24 | $-0.11 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.9M | $125.6M |
| 总债务越低越好 | $19.2M | $367.6M |
| 股东权益账面价值 | $55.5M | $476.9M |
| 总资产 | $103.1M | $1.1B |
| 负债/权益比越低杠杆越低 | 0.35× | 0.77× |
8季度趋势，按日历期对齐
现金及短期投资MVISVREX
| Q1 26 | — | $125.6M | ||
| Q4 25 | $74.9M | $155.1M | ||
| Q3 25 | $99.5M | $152.6M | ||
| Q2 25 | $91.4M | $223.0M | ||
| Q1 25 | $69.0M | $212.6M | ||
| Q4 24 | $74.7M | — | ||
| Q3 24 | $43.2M | $200.5M | ||
| Q2 24 | $56.6M | $190.0M |
总债务MVISVREX
| Q1 26 | — | $367.6M | ||
| Q4 25 | $19.2M | $367.5M | ||
| Q3 25 | $29.0M | $367.5M | ||
| Q2 25 | $32.3M | $567.2M | ||
| Q1 25 | $30.1M | $567.0M | ||
| Q4 24 | $33.0M | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
股东权益MVISVREX
| Q1 26 | — | $476.9M | ||
| Q4 25 | $55.5M | $472.6M | ||
| Q3 25 | $90.7M | $455.3M | ||
| Q2 25 | $77.1M | $549.7M | ||
| Q1 25 | $53.2M | $540.2M | ||
| Q4 24 | $48.8M | — | ||
| Q3 24 | $65.9M | $529.1M | ||
| Q2 24 | $78.7M | $581.2M |
总资产MVISVREX
| Q1 26 | — | $1.1B | ||
| Q4 25 | $103.1M | $1.1B | ||
| Q3 25 | $150.8M | $1.1B | ||
| Q2 25 | $140.6M | $1.4B | ||
| Q1 25 | $116.7M | $1.3B | ||
| Q4 24 | $121.2M | — | ||
| Q3 24 | $88.3M | $1.2B | ||
| Q2 24 | $103.4M | $1.3B |
负债/权益比MVISVREX
| Q1 26 | — | 0.77× | ||
| Q4 25 | 0.35× | 0.78× | ||
| Q3 25 | 0.32× | 0.81× | ||
| Q2 25 | 0.42× | 1.03× | ||
| Q1 25 | 0.57× | 1.05× | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.4M | $-16.1M |
| 自由现金流经营现金流 - 资本支出 | $-15.6M | $-26.8M |
| 自由现金流率自由现金流/营收 | -7017.5% | -12.8% |
| 资本支出强度资本支出/营收 | 109.4% | 5.1% |
| 现金转化率经营现金流/净利润 | — | -7.00× |
| 过去12个月自由现金流最近4个季度 | $-59.4M | $-13.3M |
8季度趋势，按日历期对齐
经营现金流MVISVREX
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $-15.4M | $7.9M | ||
| Q3 25 | $-16.5M | $7.7M | ||
| Q2 25 | $-12.7M | $16.6M | ||
| Q1 25 | $-14.1M | $9.5M | ||
| Q4 24 | $-15.1M | — | ||
| Q3 24 | $-14.1M | $25.9M | ||
| Q2 24 | $-18.6M | $8.0M |
自由现金流MVISVREX
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $-15.6M | $2.3M | ||
| Q3 25 | $-16.6M | $1.4M | ||
| Q2 25 | $-12.9M | $9.8M | ||
| Q1 25 | $-14.2M | $5.3M | ||
| Q4 24 | $-15.2M | — | ||
| Q3 24 | $-14.1M | $19.9M | ||
| Q2 24 | $-18.8M | $3.3M |
自由现金流率MVISVREX
| Q1 26 | — | -12.8% | ||
| Q4 25 | -7017.5% | 1.0% | ||
| Q3 25 | -6894.6% | 0.7% | ||
| Q2 25 | -8346.5% | 4.6% | ||
| Q1 25 | -2410.4% | 2.7% | ||
| Q4 24 | -918.7% | — | ||
| Q3 24 | -7421.1% | 9.7% | ||
| Q2 24 | -989.5% | 1.6% |
资本支出强度MVISVREX
| Q1 26 | — | 5.1% | ||
| Q4 25 | 109.4% | 2.4% | ||
| Q3 25 | 53.1% | 3.1% | ||
| Q2 25 | 134.2% | 3.2% | ||
| Q1 25 | 16.8% | 2.1% | ||
| Q4 24 | 6.2% | — | ||
| Q3 24 | 4.7% | 2.9% | ||
| Q2 24 | 8.7% | 2.2% |
现金转化率MVISVREX
| Q1 26 | — | -7.00× | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MVIS
暂无分部数据
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
